Lethal Prostate Cancer in the PLCO Cancer Screening Trial. - Wikidata - awgldk - TriplyDB

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

http://www.wikidata.org/entity/Q37008842

about

Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.Prostate cancer screening-when to start and how to screen?

P2860

Q47336394-65BC1BB3-3009-4657-AA7F-7968400C3EA8 Q52624230-4153059C-3C54-4319-957C-45B098C4FA8B

P2860

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

http://www.wikidata.org/entity/Q37008842

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@en

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@nl

type

label

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@en

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@nl

prefLabel

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@en

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

@nl

P1433

Q37008842-A37F3F75-1384-4034-83E6-C971C9AFFA0D

P1476

Q37008842-9D84DD80-EEF7-4C10-90CF-201BCA329BDD

P2093

Q37008842-20B4DED7-7965-4E67-8B6D-15574D23D6F4

Q37008842-2998A87A-AF96-4326-AB5D-CA8C90E675A3

Q37008842-AFCD07EC-73A9-450A-A338-D2BC98F484C1

Q37008842-BB6BC05E-E9B0-45C2-A5DE-B2EC46359A45

Q37008842-CE1A69D4-2046-469D-BB8E-6D9D6CAEEC45

P2860

Q37008842-286C4570-4A45-49B5-9F50-E736832F4876

Q37008842-2C7B3FE8-8E22-4B44-ADB7-EA137F748754

Q37008842-3C72EA66-9FED-4CE2-BBAF-0FF6F43A2FBA

Q37008842-777AC9E9-6C82-4032-A26B-A0B8756268A3

Q37008842-9A9009CC-C4AF-4FF5-9835-B5EE134AD3F7

Q37008842-B1C4F685-40AD-4E0B-AC73-45AE886EEDC4

Q37008842-BAC57130-3407-4ACB-B866-DD1A41B24FF0

Q37008842-BC5E86B2-1922-40EF-AECC-D5ECBB75177E

Q37008842-BC85B073-5CE2-4B2A-8EBF-BD1249AE3953

Q37008842-F06DA6F9-B93E-45FF-945D-9D3AE6E3C3E1

P304

Q37008842-F250B69A-21A6-4DC1-9D6F-F61FA9A811D9

P31

Q37008842-99C7D16B-654C-4298-98DB-CECDA0F0D42B

P356

Q37008842-AD746AF3-C1B3-4A85-B7CE-A4B1D234F161

P407

Q37008842-D5E4C6E2-28A9-437D-8BB7-87EB5A489153

P433

Q37008842-7155CEF1-687B-4E31-9E40-1E182722CCB7

P478

Q37008842-41BE05FE-FABE-4B5D-8CB0-2CD0352343B4

P50

Q37008842-2D627619-E2CF-4A21-A841-B11FA5C81280

P577

Q37008842-3BD96C58-D650-4FF0-AEFE-E93A45C1A9D9

P698

Q37008842-E806A077-7D2D-4D3D-9E44-7910C158B93D

P932

Q37008842-993C1BAE-E795-4D8A-A7DC-0544A330283B

P356

J.EURURO.2016.01.009

P1433

European Urology

P1476

Lethal Prostate Cancer in the PLCO Cancer Screening Trial

@en

P2093

Douglas Scherr

http://www.w3.org/2001/XMLSchema#string

Jim C Hu

http://www.w3.org/2001/XMLSchema#string

Jonathan Shoag

http://www.w3.org/2001/XMLSchema#string

Joshua A Halpern

http://www.w3.org/2001/XMLSchema#string

Sameer Mittal

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

ERSPC and PLCO prostate cancer screening studies: what are the differences?

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.

Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

P304

2-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2016.01.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Christopher E. Barbieri

P577

2016-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27166670

http://www.w3.org/2001/XMLSchema#string

P932

4909529

http://www.w3.org/2001/XMLSchema#string